"CD11c Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An integrin alpha subunit of approximately 150-kDa molecular weight. It is expressed at high levels on monocytes and combines with CD18 ANTIGEN to form the cell surface receptor INTEGRIN ALPHAXBETA2. The subunit contains a conserved I-domain which is characteristic of several of alpha integrins.
| Descriptor ID |
D039521
|
| MeSH Number(s) |
D12.776.395.550.200.074.875 D12.776.395.550.200.275.500 D12.776.543.550.200.093.875 D12.776.543.550.200.275.500 D12.776.543.750.705.408.100.200 D12.776.543.750.705.408.600.100.500 D12.776.543.750.705.833.249.500 D23.050.301.350.074.074 D23.050.301.350.275.500
|
| Concept/Terms |
CD11c Antigen- CD11c Antigen
- Antigen, CD11c
- Antigens, CD11c
- CD11c Antigens
- Integrin alphaX
- alphaX, Integrin
- Leu-M5 Antigens
- Antigens, Leu-M5
- Leu M5 Antigens
|
Below are MeSH descriptors whose meaning is more general than "CD11c Antigen".
Below are MeSH descriptors whose meaning is more specific than "CD11c Antigen".
This graph shows the total number of publications written about "CD11c Antigen" by people in this website by year, and whether "CD11c Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD11c Antigen" by people in Profiles.
-
Leitch CS, Natafji E, Yu C, Abdul-Ghaffar S, Madarasingha N, Venables ZC, Chu R, Fitch PM, Muinonen-Martin AJ, Campbell LE, McLean WH, Schwarze J, Howie SE, Weller RB. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016 08; 138(2):482-490.e7.
-
DiLillo DJ, Ravetch JV. Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect. Cell. 2015 May 21; 161(5):1035-1045.
-
Zhou F, Ciric B, Zhang GX, Rostami A. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2014 Dec; 178(3):447-58.
-
Honke N, Shaabani N, Zhang DE, Iliakis G, Xu HC, H?ussinger D, Recher M, L?hning M, Lang PA, Lang KS. Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes. PLoS Pathog. 2013 Oct; 9(10):e1003650.
-
Kastenmüller K, Wille-Reece U, Lindsay RW, Trager LR, Darrah PA, Flynn BJ, Becker MR, Udey MC, Clausen BE, Igyarto BZ, Kaplan DH, Kastenmüller W, Germain RN, Seder RA. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest. 2011 May; 121(5):1782-96.
-
Burt BM, Plitas G, Stableford JA, Nguyen HM, Bamboat ZM, Pillarisetty VG, DeMatteo RP. CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. J Leukoc Biol. 2008 Oct; 84(4):1039-46.